Mitsubishi Tanabe Pharma Corp's ticker is MTZPY and the CUSIP is 606813202. A total of 2 filers reported holding Mitsubishi Tanabe Pharma Corp in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $14,261,000 | -12.3% | 798,955 | -9.0% | 0.01% | +8.3% |
| Q4 2019 | $16,252,000 | +91.5% | 878,272 | +15.2% | 0.01% | +71.4% |
| Q3 2019 | $8,486,000 | -1.2% | 762,467 | -1.8% | 0.01% | 0.0% |
| Q2 2019 | $8,589,000 | -8.9% | 776,594 | +9.7% | 0.01% | -12.5% |
| Q1 2019 | $9,425,000 | -2.9% | 707,855 | +4.4% | 0.01% | -20.0% |
| Q4 2018 | $9,709,000 | +66.8% | 677,770 | +95.1% | 0.01% | +100.0% |
| Q3 2018 | $5,822,000 | -16.0% | 347,455 | -13.6% | 0.01% | -28.6% |
| Q2 2018 | $6,929,000 | -30.9% | 401,946 | -18.2% | 0.01% | -30.0% |
| Q1 2018 | $10,025,000 | +16.6% | 491,653 | +18.6% | 0.01% | +11.1% |
| Q4 2017 | $8,599,000 | -13.2% | 414,401 | -3.8% | 0.01% | -18.2% |
| Q3 2017 | $9,903,000 | +12.0% | 430,953 | +12.8% | 0.01% | 0.0% |
| Q2 2017 | $8,842,000 | +43.2% | 382,096 | +28.9% | 0.01% | +22.2% |
| Q1 2017 | $6,176,000 | +11.8% | 296,344 | +4.8% | 0.01% | +12.5% |
| Q4 2016 | $5,526,000 | +18.4% | 282,645 | +28.6% | 0.01% | +14.3% |
| Q3 2016 | $4,667,000 | +28.9% | 219,845 | +8.6% | 0.01% | +16.7% |
| Q2 2016 | $3,621,000 | +7.7% | 202,524 | +5.2% | 0.01% | +20.0% |
| Q1 2016 | $3,363,000 | – | 192,601 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|